FOXQ1 and ductal breast carcinoma in situ: 4b). Furthermore, the proliferation of ERK1 knockout DCIS-iFGFR1 cells without FOXQ1 knockdown was inhibited more than two folds by inhibiting ERK2 with PD0325901.